Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Theravance Biopharma (TBPH) over the last 10 years, with Q3 2025 value amounting to 11.27.

  • Theravance Biopharma's Interest Coverage Ratio rose 3451.03% to 11.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 13.01, marking a year-over-year increase of 2528.58%. This contributed to the annual value of 18.44 for FY2024, which is 2266.49% up from last year.
  • As of Q3 2025, Theravance Biopharma's Interest Coverage Ratio stood at 11.27, which was up 3451.03% from 4.11 recorded in Q2 2025.
  • In the past 5 years, Theravance Biopharma's Interest Coverage Ratio ranged from a high of 4.11 in Q2 2025 and a low of 45.29 during Q1 2023
  • Its 5-year average for Interest Coverage Ratio is 17.99, with a median of 17.2 in 2024.
  • As far as peak fluctuations go, Theravance Biopharma's Interest Coverage Ratio tumbled by 93697.73% in 2021, and later surged by 8314.61% in 2025.
  • Over the past 5 years, Theravance Biopharma's Interest Coverage Ratio (Quarter) stood at 26.28 in 2021, then dropped by 20.59% to 31.69 in 2022, then surged by 68.4% to 10.02 in 2023, then crashed by 42.85% to 14.31 in 2024, then rose by 21.27% to 11.27 in 2025.
  • Its Interest Coverage Ratio stands at 11.27 for Q3 2025, versus 4.11 for Q2 2025 and 22.45 for Q1 2025.